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Effects of Ginkgo Biloba on 
Memory in Rats for Maze Tasks 
Christopher DeLeon 
Coastal Carolina University 
Previous studies have investigated the effects of an 
extract of ginkgo biloba on acquisition, performance 
and retention in rats. It has been suggested that ginkgo 
increases mental precision by increasing blood flow 
to the brain. To determine whether ginkgo is a memory 
enhancer two female Sprague Dawley rats were tested 
for maze performance during four stages. Stages in-
cluded four days of maze performance and four days 
of no maze performance. Subjects were tested in each 
stage with or without ginkgo in their water supply. It 
was predicted that subjects would show improved 
maze performance as measured by a decrease in the 
number of wrong turns in reaching the goal box when 
ginkgo was mixed with their water supply. A one-way 
ANOVA was used to calculate the total number of 
wrong turns for all four stages. Results of the analy-
sis were not statistically significant. The present data 
were not consistent with results of previous studies 
with rats. Continued research is encouraged to inves-
tigate the external validity of those studies that 
proved ginkgo's effects to be beneficial to enhancing 
memory. 
Heise (1984) defined memory as the 
retention of learned memory over a period of 
time. Memory ". . .is a network of thoughts 
that's created as chemicals called neurotrans-
mitters— acetylcholine, in particular—and 
electrical impulses trace pathways through the 
brain" (Business Week, 1 999, p. 1 1 6). The 
number of synapses within brain cells increase 
with the addition of new information. 
The deterioration of memory over time 
remains a mystery. Memory loss has been 
attributed to a decreased number of brain cells 
or damage to a particular area in the brain. 
Dementia also represents a deterioration of 
memory and many factors contribute to de- 
mentia. 'Dementia is a pathology that is not 	
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part of normal aging,' says Andrew Morgan, 
chief of the neuropsychology of aging at the 
National Institute of Aging" (Business Week, 1 
999, p. 1 16). Alzheimer's, the major cause of 
dementia in old age, results from amyloid 
plaques in the hippocampus, which damage 
brain cells that produce acetylcholine. 
Alzheimer's can also trigger inflammation of 
the brain and cause free radicals to develop 
harmful oxygen molecules within the brain. 
With free radicals, " ' . . . fatty acids in the 
membranes of brain cells become oxidized, 
and the brain stops functioning properly,' says 
Jerry Cott, head of adult psychopharmacology 
research at the National Institute of Mental 
Health" (Business Week, 1 999, p. 1 16). 
Many "remedies" to Alzheimer's and 
other forms of dementia have been tested. 
Some of the so-called remedies that Cowley 
and Springen (1997) have suggested involve 
acetyl L carnitine, DMAE (a nutrient that 
stimulates the manufacture of acetylcholine), 
ginkgo biloba, ibuprofen, phosphatidylserine, 
and vitamin E. Ginkgo is the most popular 
remedy of choice. 
Kleijnen and Knipschild (1992) used the 
term cerebral insufficiency to label twelve 
symptoms that were signs of dementia in 
elderly people. The twelve symptoms that 
could be relieved by ginkgo treatment were 
difficulties of concentration and of memory, 
absent mindedness, confusion, lack of energy, 
tiredness, decreased physical performance, 
depressive mood, anxiety, dizziness, tinnitus 
and headache. Many western countries such as 
France and Germany used standard dosages of 
ginkgo in prescription medicine. "It has re-
cently been approved in Germany for the 
treatment of dementia" (Le Bars, Katz, 
Berman, Itil, Freedman, and Schatzberg, 1 
997, p. 1327). In the United States there is no 
standard dosa-ge for ginkgo. Recommended 
dosages have ranged from 60 to 80 mg twice a 
day to 40 mg tablets three times a day. How-
ever, no specific dosage has been recom-
mended as effective due to the lack of re-
search. 
Extracts of ginkgo are obtained from 
leaves of the ginkgo tree. The most popular 
extract of ginkgo biloba in Europe is EGb 761 
which is standardized with " . . . ginkgo-
flavone glycosides (24%) and terpenoids (6%)" 
(Kleijnen and Knipschild, 1992, p. 136). The 
ginkgo-flavone glycosides are used to offset 
free radicals while the terpenoids reduce 
inflammation and prevent blood clotting. As 
with other herbs, ginkgo ". . .has not been 
generally accepted by the federal drug admin-
istration for general distribution" (Kolakowsky 
and Parente', 1997, p. 12) and its potency 
cannot be predicted. 
Despite the effects of ginkgo on 
memory it should not be considered as a 
treatment for conditions that cause dementia. 
"'Ginkgo biloba is not a smart pill,' says Varro 
Tyler, PhD, professor emeritus at the Purdue 
University School of Pharmacy and a leading 
expert on herbal supplements, and 'it won't 
work for everyone' "(Tufts University Health Et 
Nutrition Letter, 1997, p.8). Ginkgo seems to 
benefit people who have trouble with blood 
flow to the brain due to advanced age and 
clogged arteries. The lack of blood flow results 
in loss of short-term memory and difficulties in 
concentration. Ginkgo acts as a blood thinner, 
which helps circulation of blood. 
Experiments on the effects of ginkgo 
started in the late eighties. Two experiments 
demonstrated that ginkgo increased blood 
flow. Kleijnen and Knipschild (1 992) reported 
on a study by Koltringer, Eber, and Lind (1989) 
that investigated the effects of ginkgo on blood 
flow. In a randomized double blind experiment, 
60 subjects were given 200-mg dosages of 
ginkgo for four consecutive days, which led to 
an increase in skin perfusion and a decrease in 
blood viscosity and elasticity. 
In another experiment studying blood 
flow Jung, Mrowietz, Kiesewetter, and Wenzel 
(1990) (cited in Kleijnen and Knipschild, 1 992) 
performed a randomized single blind study 
using 10 subjects. Each subject received 1 12 
milligram dosages of LI 13 70, which was a 
standardized preparation of ginkgo. Upon 
completion of the experiment, the subjects 
showed increased blood flow in capillaries and 
decreased erythrocyte aggregation. 
Le Bars, et al. (1997) gained worldwide 
attention for their research at the New York 
Institute for Medical Research. These investiga-
tors conducted a randomized double blind 
study with 309 subjects. They were randomly 
assigned to experimental and control groups. 
The experimental group was given 120 milli-
grams of ginkgo per dose while the control 
group received a placebo for 52 weeks. At the 
end of this time the Alzheimer' s Disease 
Assessment Scale, which is a standardized test 
to measure cognitive function, was adminis-
tered to subjects. The results indicated an 
improvement in cognitive function for 27% of 
subjects who received ginkgo compared to 14% 
who were given the placebo. The researchers 
concluded that ginkgo was safe and capable of 
delaying the process of dementia for six 
months to a year. However, the long-term 
benefits of ginkgo are still unknown. 
Ginkgo experimentation has not been 
limited to human subjects. Experimentation 
with rats has also been conducted. J.C. Winter 
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(1997) conducted research on the effects of 
EGb 761 on cognitive behavior of rats in a 
radial maze. In this experiment 20-month-old 
male Fisher 344 rats were assigned a diet that 
included either ginkgo biloba extract or no 
extract. Over several weeks, the animals 
performed tasks in the radial maze that re-
quired them to master new challenges and 
retain learned information over time. Results 
showed that rats receiving ginkgo biloba ex-
tract learned quicker and made fewer errors 
than the control group, and unexpectedly, 
lived an average of five months longer. Winter 
found that a significant positive relationship 
between the amount of active ingredient and 
degree of learning. The standard dose during 
most of the study was 50 mg/kg. However, one 
sub-group of animals was assigned to receive 
EGb 761 in doses of 1 00 mg/kg followed by 
200 mg/kg, interspersed with periods when 
they performed tasks while receiving no ex-
tract. Results showed that at the highest dose, 
errors declined by 50 percent. 
A year after his work with cognitive 
behavior in rats, Winter and Timineri (1998) 
conducted a study with rats to investigate the 
stimulus properties of EGb 761 . The investiga-
tors hypothesized that ginkgo administered via 
intraperitoneal injections could trigger stimu-
lus control. The subjects were nine male 
Fisher-344 rats. Subjects were tested on 
performance in an animal test chamber " . . . 
containing two levers mounted at opposite 
ends of one wall" (Winter, 1998, p. 544). Upon 
pressing the appropriate lever, ". . .a dipper. . 
.delivered 0.1 ml of sweetened condensed milk 
diluted 2:1 with tap water" (Winter, 1998, p. 
544). Prior to testing, subjects were given a 
dosage of 10 mg/kg of ginkgo in order to 
establish "stimulus control" (Winter, 1998, p. 
544). A fixed-ratio 10 schedule was used for 
liquid reinforcement during testing sessions. 
Every tenth response to the appropriate lever 
was reinforced. "Drug-induced stimulus control 
was assumed to be present when, in five 
consecutive sessions, 83% or more of all re-
sponses prior to the delivery of the first rein-
forcer were on the appropriate lever" (Winter, 
1998, p. 544). The results indicated that rats 
required an average of 24 sessions to reach the 
desired criterion. These findings supported the 
hypothesis. 
Eva Winter (1 989) conducted an experi-
ment to study the effects of EGb 761 on learn-
ing and memory in rats. Performance, acquisi-
tion, and retention in mice were measured 
with an operant box. During the conditioning 
stage, subjects were trained for 30 days in 
order to learn a two-lever response that re-
sulted in food reward. Subjects were randomly 
assigned either to an experimental or a control 
group. Experimental groups received a 1 00 
mg/kg dosage of ginkgo. Control groups re-
ceived a placebo. "Drug treatment started four 
and eight weeks before the training and was 
maintained until a retention test 1 0 weeks 
after it" (Winter, 1 989, p. 109). Performance 
involved lever pressing in a sequence (correct 
response) that led to the availability of food 
reward. Acquisition was determined by the 
ratio of correct to incorrect responses. Reten-
tion was measured 1 0 weeks after the condi-
tioning stage. The results revealed that the 
experimental groups made more correct re-
sponses than the control groups. Experimental 
groups also showed a faster acquisition rate 
than control groups. Retention testing proved 
"EGb 761- treated mice performed more 
correct responses than the controls. . . " 
(Winter, 1 989, p. 1 1 3). The researcher 
concluded that ginkgo quickened acquisition, 
increased performance, and improved reten-
tion of learned responses. 
Gajewski and Hensch (1999) conducted 
a study on the effects of ginkgo on rat perfor-
mance in a maze. Five rats were tested with a 
within-subjects design. Subjects ran through 
four mazes. Maze performance was based on 
the amount of wrong turns before reaching the 
goat box. Ginkgo availability was alternated 
with the use of each maze, i.e.; a mixture of 
ginkgo and water was available for mazes two 
and four while regular water was available for 
mazes one and three. Results indicated a 
decrease in wrong turns by 8% and 60% when 
ginkgo was added to the drinking water. The 
decrease was not as significant after the 
reintroduction of ginkgo. "The decrease in the 
number of wrong turns. . .when ginkgo was 
reintroduced into the diet was less dramatic 
(5% to 26%)" (Gajewski and Hensch, 1 999, p. 
483). The researchers concluded that rats 
demonstrated improved maze performance 
(fewer wrong turns) whenever the ginkgo 
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water mixture was available, implying that 
ginkgo improved memory. 
Although still in the early stages, re-
search on ginkgo biloba seems promising with 
respect to memory improvement. Thus addi-
tional research is necessary and important to 
understand how ginkgo affects the nervous 
system and what those effects are. 
In the present study effects of ginkgo 
biloba on memory in rats was tested on maze 
performance during four stages. Maze perfor-
mance was measured by the number of turns 
required to reach the goal box. Stages included 
four days of maze performance and four days 
of no maze running. Subjects were tested in 
each stage with or without ginkgo in their 
water supply. The researcher hypothesized that 
the availability of ginkgo would result in a 
decrease in the number of wrong turns re-
quired to reach the goal box. 
METHOD 
Design 
This experiment involved a within subject 
design with an A-B-A-B reversal. 
Participants 
Five white female Sprague Dawley rats 
were purchased from Charles River Breeding 
Laboratories, Inc. (Wilmington, MA) at the age 
of twenty-one days. At the beginning of this 
experiment they were approximately sixteen 
months old, with an average weight of 250.6 g 
prior to being food deprived to 90% of their 
body weight. During the food deprivation 
period three rats died. The researcher contin-
ued the study with two subjects. Animals were 
housed one rat per cage and maintained with 
constant temperature conditions. Illumination 
was provided by a fifty-five watt light bulb 
that operated on a twelve-hour cycle. Access 
to water was unlimited and access to food was 
unlimited prior to deprivation. 
Apparatus 
Animals were housed in standard 
plexiglass cages measuring approximately 23 .5 
x 1 5 x 9 in. Four separate mazes were con-
structed for use in this study. Each maze 
consisted of four 11.5 x 5 x 5 in connecting 
arms, four 12 x 5 x 5 in dead ends and two 7.5 
x 6 x 5 in start and goal boxes. Pictures of the 
maze pieces appear in Appendix A. All mazes 
were placed on the floor. Pictures of the actual 
mazes appear in Appendix B. A Denver Instru- 60  
ment Company digital scale (TR-402) was used 
to measure weight in grams. An Ohaus digital 
scale (CS-200) was used to measure water in 
ounces. A Sony Handycam Vision camcorder 
(CCD-TRV67) was used with a Sony P6-120MPD 
videocassette to record all rat activity in the 
mazes. 
Materials 
Herbal Authority Ginkgo Leaf manufac-
tured by United Vitamin Manufacturing Corp. 
(Bohemia, NY) was used in this study. This 
liquid form of the herbal extract was mixed 
with water to be ingested orally by the sub-
jects. A calibrated dropper was purchased with 
the herbal extract for ease of measuring. The 
rats received a dosage of fifty mg/kg of ginkgo 
mixed with three ml of water for four days 
preceding and during Stages 2 and 4 of this 
research. Water intake was recorded daily. 
Animals were fed Hartz Guinea Pig Pellets. 
Procedure 
Animals were initially weighed in order 
to determine approximate body weight. For 2 
weeks food amount was measured in order to 
determine how much each rat actually con-
sumed. Once intake baseline was obtained 
food deprivation was initiated. Daily food 
amounts were reduced until animals reached 
90% of their initial body weight. During the 
experiment animals were maintained at this 
weight. 
An A-B-A-B reversal design was utilized 
in this study. During Stage 1 the rats were 
tested on the first maze (Ml) design without 
any ginkgo. Upon completion of Stage 1 ginkgo 
was made available to each subject. The water 
was changed to include a dosage of fifty mg/kg 
of ginkgo mixed with three ml water. This 
ginkgo and water mixture was available during 
the four nonrunning days that separated Stages 
1 and 2 and the four days of maze running in 
Stage 2. A different maze (M2) design, similar 
in length and turns to the first one, was used 
to measure maze performance. 
At the conclusion of Stage 2 the ginkgo 
and water mixture was replaced by plain 
water. The water was available for four non-
running days, which initiated Stage 3. At the 
conclusion of these four days another maze 
(M3) design, similar in length and turns to 
those used in Stages 1 and 2, was used to 
measure maze performance for four days. 
Following maze testing the water was again 
replaced with the water and ginkgo mixture. 
This mixture was available during four non-
running days of Stage 4. A fourth and final 
maze (M4) pattern, similar in length and turns 
to those used previously, was used to measure 
maze performance for four more days. After 
this final session animals were returned to food 
and water ad lib. 
Results 
The dependent variable in this study 
was number of wrong turns in a maze. The 
independent variables were experimental 
stages and whether or not ginkgo was available 
in the subject's water supply. Two performance 
measures were calculated. The total number of 
wrong turns for each rat for each of the 16 
trials in all four stages appears in Figure 1. 
These data were simply determined by adding 
the number of wrong turns for each subject in 
each stage. For each subject there were four 
values. The investigator also calculated the 
increase and decrease in the number of errors 
between the stages. These data appear in 
Table 1. Difference scores were obtained by 
subtracting the total number of wrong turns for 
the given stage from the total number of 
wrong turns in the subsequent stage (B1-Al, A2-
B1, and B2-A2). This score was then divided by 
the total number of wrong turns in the previ-
ous stage and rounded to two decimal places. 
Negative scores indicated an improvement 
from the previous stage. 
Subject 1 performed a total of 260 
wrong turns for all four stages with a mean of 
65.00 and a standard deviation of 27.43. 
Subject 2 performed a total of 300 wrong turns 
for all four stages with a mean of 75.00 and a 
standard deviation of20.12. Both subjects 
performed a total of 165 wrong turns for Stage 
1 with a mean of 82.50 and a standard devia-
tion of 13.44. For Stage 2 both subjects per-
formed a total of 1 78 wrong turns for with a 
mean of 89.00 and a standard deviation of 2 1 
.2 1. Both subjects performed a total of 90 
wrong turns for Stage 3 with a mean of 45 .00 
and a standard deviation of 25 .46 and for 
Stage 4 both subjects performed a total of 127 
wrong turns with a mean of 63.50 and a stan-
dard deviation of 4.95. For Subject 1 the mean 
difference score was .21 and the standard 
deviation of 1.12. For Subject 2 the mean 
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different score was -.01 and the standard 
deviation of .41. A one-way repeated-measures 
analysis of variance (ANOVA) was calculated to 
examine the total number of wrong turns for 
all four stages. The results of the analysis did 
not reveal a significant effect for number of 
wrong turns in each stage of maze perfor-
mance as a function of availability of ginkgo in 
water, F (3, 4) = 2.42, p 
> .05. 
DISCUSSION 
Subjects performed maze running in 
four different mazes with or without the 
availability of ginkgo biloba. Several observa-
tions were made in reviewing the individual 
performances of the subjects (see Figure 1). 
The first subject showed an improvement in 
performance when ginkgo was first introduced 
into the water supply during Stage 2. The 
number of wrong turns between Stages Al and 
B1 decreased by 18. On the other hand, sub-
ject 2 showed a decline in maze performance 
between the same stages. The total number of 
wrong turns between Stages Al to B1 increased 
by 31. Secondly both subjects showed im-
proved performance when ginkgo was removed 
from their drinking water (B 1 to A2). The 
number of wrong turns for subject 1 decreased 
by 47. Similarly, the number of wrong turns for 
subject 2 decreased by 41. Also both subjects 
showed a difference in maze performance 
when ginkgo was reintroduced a second time. 
Number of wrong turns for subject 1 increased 
by 40 and this value for subject 2 decreased by 
3. It should be noted that subject 1 showed a 
148% increase in errors between Stages A2 and 
B2. Gajewski and Hensch (1999) tested maze 
performance on rats using five subjects. The 
researchers observed that there was improved 
performance when ginkgo was introduced, 
which was predicted. They also noted that 
when ginkgo was not available in the water 
supply, all five subjects showed a decline in 
performance as predicted. A final finding was 
that four of the five subjects improved perfor-
mance when ginkgo was reintroduced. 
Although the results of this study were 
not statistically significant, the effects of 
ginkgo seemed to differentially effect the two 
subjects in this study. Maze performance for 
subject improved in each of the first three 
stages (Al to B 1, B 1 to A2) but then errors 
increased during the final stage (see Table 1). 
Subject 1 made 27 errors in Stage 3 and 67 
errors in Stage 4. The subject's percent in-
crease in errors may have been caused by a 
ceiling effect, which perhaps limited the 
possibility of improvement. In contrast, initial 
maze performance for subject 2 was very poor 
with respect to number of errors but gradually 
improved in the final three stages (B 1 to A2, 
A2 to B2). According to Gajewski and Hensch (1 
999) "If poor initial performance on the task 
were due to poor circulation in the brain, the 
largest improvements would be expected for 
mice whose initial performance was the worst" 
(p.483). 
Due to time constraints many confounds 
in this study could not be avoided or resolved. 
This researcher intended to test five subjects. 
However prior to maze performance, three 
subjects died. The original food deprivation 
procedure used in this study involved reducing 
subjects body weight to eighty percent of their 
initial weight. Food reduction, plus stress and 
age may have contributed to the deaths of the 
three subjects. Perhaps all five subjects could 
have been used in data collection if food 
deprivation had initially involved reducing 
subjects body weight to ninety percent of their 
original weight. 
The weight of the rats prior to maze 
testing may have been another confound. 
While weights ranged from 284.2 g to 223.4 g, 
rats were food deprived by the same amount of 
food in order to reach ninety percent of their 
body weight. This deprivation procedure may 
have been stressful for heavier rats who were 
accustomed to eating a certain amount of 
food. Stress may have contributed to greater 
anxiety during maze performance, thus causing 
an increased number of wrong turns during 
maze performance. The Yerkes-Dodson law 
states, ". . .that easy tasks are best accom-
plished with a relatively high level of [ but 
more difficult tasks are better accomplished 
with a low or moderate level.. ." (Ormrod, 
1999, p. 424). In order to reduce the effect of 
this confound anxiety levels within subjects 
should be reduced. Animals of similar weight 
should have been used in the research. 
Other methodological problems in- 
condition in which they were received. As 
shown in Appendix A, only start and goal boxes 
had wire bottoms. The wiring may have af-
fected the results of the research by serving as 
a marker for the start and end of the maze. 
This confound could have been corrected by 
removing the wire from the start and goal box. 
Installing wire on all maze parts would have 
been problematic since parts had to be moved 
to create different maze designs. 
During Stages 1 through 4 the amount of 
water or ginkgo mixture consumed was re-
corded. However, during the initial placement 
of water bottles into rat cages the researcher 
observed that the contents of the water bottle 
would drip for several seconds. This water loss 
could not be recorded or controlled for due to 
the construction of the water bottles. No 
solution to this problem could be developed to 
avoid this confound. 
Another problem in this study involved 
testing times. Data collection during days of 
maze performance occurred at different times 
of the day depending on the researcher's 
schedule. The majority of the data was col-
lected during the late afternoon. The re-
searcher observed that subjects seemed live-
lier during certain times of the day. When 
maze performance was measured during the 
early morning or late afternoon rats were 
constantly exploring the maze parts. When 
they reached the goal box and then were 
placed back in the start box, subjects ap-
peared quick to search for the goal box again. 
On the other hand, maze performance during 
the early afternoon was different. Rats ap-
peared unmotivated to explore the maze parts. 
When they finally reached the goal box and 
were placed back in the start box, the food 
reward did not seem to motivate them to 
search for food again. It seems reasonable to 
assume that activity levels vary according to 
some circadian cycle or other biological cycle. 
Thus maze performance could have been 
affected by time of day for testing since this 
variable was not controlled for. 
Extraneous noises may have interfered 
with subjects' performance in this study. 
During maze running the researcher placed a 
notice on the door to prevent people from 
volved the apparatus and equipment. The 	 entering the testing area. In addition, all 
researcher maintained all maze pieces in the 	 appliances capable of producing sounds were 
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unplugged to prevent unnecessary noises. 
However, not all sounds could be prevented. 
The testing area was located next to a main 
hall that led to a main entrance to the build-
ing. Also, the men's restroom was located next 
to the testing area. The researcher heard the 
restroom doors open and close during times of 
heavy traffic in the halls. 
A final problem with this study was the 
fact that rats had been used in previous re-
search. This may have confounded the results. 
It is unknown to the researcher as to what 
types of research the rats had previously 
participated in or the outcomes of that re-
search. 
Some data were collected in this study 
but not statistically analyzed. The amount of 
food distributed, leftover and consumed was 
recorded daily for each subject. In addition, 
the researcher recorded the amount of water 
or ginkgo mixture consumed. Future research-
ers should maintain careful records of this data 
and include it in statistical analyses. 
It is important to continue research in 
this area because there is no available cure for 
dementia. Alzheimer's Disease is the most 
common form of primary degenerative demen-
tia and the fourth leading cause of death in 
persons 65 years of age and older. Cognex, an 
FDA approved acetycholine enhancing drug is 
currently used to slow the process of 
Alzheimer's. However, it is not easily tolerable 
because of unpleasant side effects. While it is 
unclear whether or not ginkgo biloba has the 
ability to enhance memory or slow the demen-
tia process, research should continue with 
emphasis "...to identify the neurochemical 
mechanisms responsible for this possible 
enhancement of memory.. ." (Gajewski and 
Hensch, 1999, p. 484). 
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